Email updates

Keep up to date with the latest news and content from BMC Neuroscience and BioMed Central.

Open Access Highly Accessed Research article

Progranulin is expressed within motor neurons and promotes neuronal cell survival

Cara L Ryan1, David C Baranowski14, Babykumari P Chitramuthu14, Suneil Malik1, Zhi Li1, Mingju Cao1, Sandra Minotti2, Heather D Durham2, Denis G Kay4, Christopher A Shaw3, Hugh PJ Bennett1* and Andrew Bateman1

Author affiliations

1 Endocrine Research Laboratory, Royal Victoria Hospital and Department of Medicine, McGill University Health Centre Research Institute, 687 Pine Avenue West, Montreal, Quebec, H3A 1A1, Canada

2 Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada

3 University of British Columbia, Departments of Ophthalmology and Visual Sciences, and Experimental Medicine and Graduate Program in Neuroscience, Vancouver, British Columbia, V5Z 1L8, Canada

4 Neurodyn Inc., Suite 508, NRC-INH, 550 University Avenue, Charlottetown, Prince Edward Island, C1A 4P3, Canada

For all author emails, please log on.

Citation and License

BMC Neuroscience 2009, 10:130  doi:10.1186/1471-2202-10-130

Published: 27 October 2009

Abstract

Background

Progranulin is a secreted high molecular weight growth factor bearing seven and one half copies of the cysteine-rich granulin-epithelin motif. While inappropriate over-expression of the progranulin gene has been associated with many cancers, haploinsufficiency leads to atrophy of the frontotemporal lobes and development of a form of dementia (frontotemporal lobar degeneration with ubiquitin positive inclusions, FTLD-U) associated with the formation of ubiquitinated inclusions. Recent reports indicate that progranulin has neurotrophic effects, which, if confirmed would make progranulin the only neuroprotective growth factor that has been associated genetically with a neurological disease in humans. Preliminary studies indicated high progranulin gene expression in spinal cord motor neurons. However, it is uncertain what the role of Progranulin is in normal or diseased motor neuron function. We have investigated progranulin gene expression and subcellular localization in cultured mouse embryonic motor neurons and examined the effect of progranulin over-expression and knockdown in the NSC-34 immortalized motor neuron cell line upon proliferation and survival.

Results

In situ hybridisation and immunohistochemical techniques revealed that the progranulin gene is highly expressed by motor neurons within the mouse spinal cord and in primary cultures of dissociated mouse embryonic spinal cord-dorsal root ganglia. Confocal microscopy coupled to immunocytochemistry together with the use of a progranulin-green fluorescent protein fusion construct revealed progranulin to be located within compartments of the secretory pathway including the Golgi apparatus. Stable transfection of the human progranulin gene into the NSC-34 motor neuron cell line stimulates the appearance of dendritic structures and provides sufficient trophic stimulus to survive serum deprivation for long periods (up to two months). This is mediated at least in part through an anti-apoptotic mechanism. Control cells, while expressing basal levels of progranulin do not survive in serum free conditions. Knockdown of progranulin expression using shRNA technology further reduced cell survival.

Conclusion

Neurons are among the most long-lived cells in the body and are subject to low levels of toxic challenges throughout life. We have demonstrated that progranulin is abundantly expressed in motor neurons and is cytoprotective over prolonged periods when over-expressed in a neuronal cell line. This work highlights the importance of progranulin as neuroprotective growth factor and may represent a therapeutic target for neurodegenerative diseases including motor neuron disease.